Related Experiment Videos
[Acute respiratory distress syndrome]
M Matĕjovic1, I Novák, V Srámek
1I. interní klinika LF UK a FN, Plzen.
Casopis Lekaru Ceskych
|July 28, 1999
Summary
Acute respiratory distress syndrome (ARDS) causes severe lung failure and high mortality. Current management is supportive, focusing on underlying conditions and oxygenation, as specific therapies are still under evaluation.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Pathophysiology
Background:
- Acute respiratory distress syndrome (ARDS) is a severe respiratory failure with diverse causes, high mortality (50-70%), and significant financial burden.
- ARDS pathogenesis involves a systemic inflammatory response leading to diffuse lung inflammation, alveolar-endothelial damage, increased capillary permeability, and lung water accumulation.
- Commonly associated with sepsis and multiple organ failure, ARDS presents with hypoxemia, pulmonary edema, decreased lung compliance, and pulmonary hypertension.
Purpose of the Study:
- To review the definition, pathogenesis, and pathophysiology of ARDS.
- To discuss current therapeutic strategies and possibilities for managing ARDS.
Main Methods:
- Literature review of ARDS definition, pathogenesis, pathophysiology.
- Analysis of current therapeutic concepts and ongoing research.
Main Results:
- ARDS is characterized by diffuse lung injury and impaired gas exchange, regardless of the initial cause.
- Despite advances, ARDS management remains primarily supportive, aiming to address underlying causes and maintain oxygenation.
- Numerous novel therapeutic strategies are emerging but require further scientific validation.
Conclusions:
- ARDS represents a critical unmet medical need with substantial morbidity and mortality.
- Effective ARDS management necessitates a multi-faceted approach, including supportive care and addressing the underlying inflammatory cascade.
- Future research into specific therapeutic interventions holds promise for improving ARDS outcomes.